Health CanadaGeneral Alert
Association of Microangiopathic anemia with the combined use of AVASTIN (bevaciz...
Published: July 11, 2008Recall ID: 24374Category: generalCountry: Canada
Product Description & Identification
Association of Microangiopathic anemia with the combined use of AVASTIN (bevacizumab) and sunitinib malate in metastatic renal cell carcinoma - Notice to Hospitals
Additional Source Details
| Field | Value |
|---|---|
| N I D | 24374 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/association-microangiopathic-anemia-combined-use-avastin-bevacizumab-and-sunitinib |
| Title | Association of Microangiopathic anemia with the combined use of AVASTIN (bevacizumab) and sunitinib malate in metastatic renal cell carcinoma - Notice to Hospitals |
| Archived | 1 |
| Category | Drugs - Biologic or vaccine |
| Last updated | 2008-07-11 |
| Organization | Marketed health products |